{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:33:10Z","timestamp":1793057590118,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41590-026-02685-2","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:56:23Z","timestamp":1792014983000},"page":"2238-2251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Compartment-specific PPAR\u03b4 activity controls the outcome of cancer\u2013immune cell competition and immunotherapy efficacy"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3564-7165","authenticated-orcid":false,"given":"Paul","family":"Bunk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-6502","authenticated-orcid":false,"given":"Ilgin","family":"Ergin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6874-5285","authenticated-orcid":false,"given":"Vyom","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh B. S. S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Wellhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Moresco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4432-4098","authenticated-orcid":false,"given":"Sarah","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Habel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Mandati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Rivadeneira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4244-4673","authenticated-orcid":false,"given":"Laura","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M. K.","family":"Westcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9532-7051","authenticated-orcid":false,"given":"Samuel E.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saar I.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie Y. R.","family":"Agar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4730-4012","authenticated-orcid":false,"given":"Semir","family":"Beyaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2685_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229\u20131241 (2015).","journal-title":"Cell"},{"key":"2685_CR2","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel, A. E. et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell 183, 1848\u20131866 (2020).","journal-title":"Cell"},{"key":"2685_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"P-C Ho","year":"2015","unstructured":"Ho, P. -C. et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162, 1217\u20131228 (2015).","journal-title":"Cell"},{"key":"2685_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06256-5","volume":"619","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Reprogramming tumour-associated macrophages to outcompete cancer cells. Nature 619, 616\u2013623 (2023).","journal-title":"Nature"},{"key":"2685_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 374\u2013388 (2016).","journal-title":"Immunity"},{"key":"2685_CR6","first-page":"e70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H. & Jemal, A. Cancer statistics, 2026. CA Cancer J. Clin. 76, e70043 (2026).","journal-title":"CA Cancer J. Clin."},{"key":"2685_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh, K. et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat. Rev. Gastroenterol. Hepatol. 16, 361\u2013375 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2685_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"2685_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nm993","volume":"10","author":"RA Gupta","year":"2004","unstructured":"Gupta, R. A. et al. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat. Med. 10, 245\u2013247 (2004).","journal-title":"Nat. Med."},{"key":"2685_CR10","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1073\/pnas.1324233111","volume":"111","author":"D Wang","year":"2014","unstructured":"Wang, D. et al. Peroxisome proliferator-activated receptor \u03b4 promotes colonic inflammation and tumor growth. Proc. Natl Acad. Sci. USA 111, 7084\u20137089 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2685_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1158\/0008-5472.CAN-18-1790","volume":"79","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Pleiotropic effects of PPARD accelerate colorectal tumorigenesis, progression, and invasion. Cancer Res. 79, 954\u2013969 (2019).","journal-title":"Cancer Res."},{"key":"2685_CR12","doi-asserted-by":"publisher","first-page":"dju052","DOI":"10.1093\/jnci\/dju052","volume":"106","author":"X Zuo","year":"2014","unstructured":"Zuo, X. et al. Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-\u03b4\/\u03b2 overexpression. J. Natl Cancer Inst. 106, dju052 (2014).","journal-title":"J. Natl Cancer Inst."},{"key":"2685_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature17173","volume":"531","author":"S Beyaz","year":"2016","unstructured":"Beyaz, S. et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531, 53\u201358 (2016).","journal-title":"Nature"},{"key":"2685_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.stem.2021.03.001","volume":"28","author":"S Beyaz","year":"2021","unstructured":"Beyaz, S., Mana, M. D. & Yilmaz, \u00d6 High-fat diet activates a PPAR-\u03b4 program to enhance intestinal stem cell function. Cell Stem Cell 28, 598\u2013599 (2021).","journal-title":"Cell Stem Cell"},{"key":"2685_CR15","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1158\/2159-8290.CD-22-0661","volume":"12","author":"J Abrego","year":"2022","unstructured":"Abrego, J. et al. A cancer cell-intrinsic GOT2-PPAR\u03b4 axis suppresses antitumor immunity. Cancer Discov. 12, 2414\u20132433 (2022).","journal-title":"Cancer Discov."},{"key":"2685_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm1026","volume":"10","author":"FS Harman","year":"2004","unstructured":"Harman, F. S. et al. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. Nat. Med. 10, 481\u2013483 (2004).","journal-title":"Nat. Med."},{"key":"2685_CR17","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-05-4277","volume":"66","author":"HE Marin","year":"2006","unstructured":"Marin, H. E. et al. Ligand activation of peroxisome proliferator\u2013activated receptor \u03b2 inhibits colon carcinogenesis. Cancer Res. 66, 4394\u20134401 (2006).","journal-title":"Cancer Res."},{"key":"2685_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","volume":"32","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell 32, 377\u2013391 (2017).","journal-title":"Cancer Cell"},{"key":"2685_CR19","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-18-0095","volume":"6","author":"PS Chowdhury","year":"2018","unstructured":"Chowdhury, P. S., Chamoto, K., Kumar, A. & Honjo, T. PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy. Cancer Immunol. Res. 6, 1375\u20131387 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"2685_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1158\/0008-5472.CAN-17-3053","volume":"79","author":"SD Saibil","year":"2019","unstructured":"Saibil, S. D. et al. Activation of peroxisome proliferator-activated receptors \u03b1 and \u03b4 synergizes with inflammatory signals to enhance adoptive cell therapy. Cancer Res. 79, 445\u2013451 (2019).","journal-title":"Cancer Res."},{"key":"2685_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adn2717","volume":"9","author":"A Bevilacqua","year":"2024","unstructured":"Bevilacqua, A. et al. PPAR\u03b2\/\u03b4-orchestrated metabolic reprogramming supports the formation and maintenance of memory CD8+ T cells. Sci. Immunol. 9, eadn2717 (2024).","journal-title":"Sci. Immunol."},{"key":"2685_CR22","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1158\/2767-9764.CRC-24-0264","volume":"4","author":"B Cen","year":"2024","unstructured":"Cen, B., Wei, J., Wang, D. & DuBois, R. N. Peroxisome proliferator-activated receptor \u03b4 suppresses the cytotoxicity of CD8+ T cells by inhibiting RelA DNA-binding activity. Cancer Res. Commun. 4, 2673\u20132684 (2024).","journal-title":"Cancer Res. Commun."},{"key":"2685_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat. Immunol. 21, 298\u2013308 (2020).","journal-title":"Nat. Immunol."},{"key":"2685_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","volume":"7","author":"JI Odegaard","year":"2008","unstructured":"Odegaard, J. I. et al. Alternative M2 activation of Kupffer cells by PPAR\u03b4 ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496\u2013507 (2008).","journal-title":"Cell Metab."},{"key":"2685_CR25","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","volume":"19","author":"X Michelet","year":"2018","unstructured":"Michelet, X. et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat. Immunol. 19, 1330\u20131340 (2018).","journal-title":"Nat. Immunol."},{"key":"2685_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-6-15","volume":"6","author":"A Defaux","year":"2009","unstructured":"Defaux, A., Zurich, M. G., Braissant, O., Honegger, P. & Monnet-Tschudi, F. Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. J. Neuroinflammation 6, 15 (2009).","journal-title":"J. Neuroinflammation"},{"key":"2685_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.brainres.2010.12.059","volume":"1376","author":"S Kanakasabai","year":"2011","unstructured":"Kanakasabai, S., Walline, C. C., Chakraborty, S. & Bright, J. J. PPAR\u03b4 deficient mice develop elevated Th1\/Th17 responses and prolonged experimental autoimmune encephalomyelitis. Brain Res. 1376, 101\u2013112 (2011).","journal-title":"Brain Res."},{"key":"2685_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103\u2013107 (2009).","journal-title":"Nature"},{"key":"2685_CR29","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2018.06.002","volume":"28","author":"B Raud","year":"2018","unstructured":"Raud, B. et al. Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation. Cell Metab. 28, 504\u2013515 (2018).","journal-title":"Cell Metab."},{"key":"2685_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302878120","volume":"120","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing. Proc. Natl Acad. Sci. USA 120, e2302878120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2685_CR31","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/s41388-018-0384-z","volume":"37","author":"YN Wang","year":"2018","unstructured":"Wang, Y. N. et al. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis. Oncogene 37, 6025\u20136040 (2018).","journal-title":"Oncogene"},{"key":"2685_CR32","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","volume":"3","author":"F Hossain","year":"2015","unstructured":"Hossain, F. et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer Immunol. Res. 3, 1236\u20131247 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"2685_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nbt.3836","volume":"35","author":"J Roper","year":"2017","unstructured":"Roper, J. et al. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat. Biotechnol. 35, 569\u2013576 (2017).","journal-title":"Nat. Biotechnol."},{"key":"2685_CR34","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s43018-021-00247-z","volume":"2","author":"PMK Westcott","year":"2021","unstructured":"Westcott, P. M. K. et al. Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer. Nat. Cancer. 2, 1071\u20131085 (2021).","journal-title":"Nat. Cancer."},{"key":"2685_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109212","volume":"35","author":"MD Mana","year":"2021","unstructured":"Mana, M. D. et al. High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity. Cell Rep. 35, 109212 (2021).","journal-title":"Cell Rep."},{"key":"2685_CR36","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734\u20134752 (2021).","journal-title":"Cell"},{"key":"2685_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"2685_CR38","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568\u2013571 (2014).","journal-title":"Nature"},{"key":"2685_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman, W. H., Pag\u00e8s, F., Saut\u00e8s-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 12, 298\u2013306 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2685_CR40","doi-asserted-by":"publisher","first-page":"16723","DOI":"10.1073\/pnas.1110814108","volume":"108","author":"J Yuan","year":"2011","unstructured":"Yuan, J. et al. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc. Natl Acad. Sci USA 108, 16723\u201316728 (2011).","journal-title":"Proc. Natl Acad. Sci USA"},{"key":"2685_CR41","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","volume":"50","author":"MT Chow","year":"2019","unstructured":"Chow, M. T. et al. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy. Immunity 50, 1498\u20131512 (2019).","journal-title":"Immunity"},{"key":"2685_CR42","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1073\/pnas.052707099","volume":"99","author":"Y Shi","year":"2002","unstructured":"Shi, Y., Hon, M. & Evans, R. M. The peroxisome proliferator-activated receptor \u03b4, an integrator of transcriptional repression and nuclear receptor signaling. Proc. Natl Acad. Sci. USA 99, 2613\u20132618 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2685_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn, R. C. et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature 576, 293\u2013300 (2019).","journal-title":"Nature"},{"key":"2685_CR44","doi-asserted-by":"publisher","first-page":"9058","DOI":"10.1074\/jbc.M209999200","volume":"278","author":"M Morillas","year":"2003","unstructured":"Morillas, M. et al. Identification of conserved amino acid residues in rat liver carnitine palmitoyltransferase I critical for malonyl-CoA inhibition: mutation of methionine 593 abolishes malonyl-CoA inhibition. J. Biol. Chem. 278, 9058\u20139063 (2003).","journal-title":"J. Biol. Chem."},{"key":"2685_CR45","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature14362","volume":"520","author":"S Schoors","year":"2015","unstructured":"Schoors, S. et al. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520, 192\u2013197 (2015).","journal-title":"Nature"},{"key":"2685_CR46","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1084\/jem.20091663","volume":"207","author":"SE Dunn","year":"2010","unstructured":"Dunn, S. E. et al. Peroxisome proliferator\u2013activated receptor \u03b4 limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J. Exp. Med. 207, 1599\u20131608 (2010).","journal-title":"J. Exp. Med."},{"key":"2685_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","volume":"391","author":"M Ricote","year":"1998","unstructured":"Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. & Glass, C. K. The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation. Nature 391, 79\u201382 (1998).","journal-title":"Nature"},{"key":"2685_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.1087344","volume":"302","author":"C-H Lee","year":"2003","unstructured":"Lee, C. -H. et al. Transcriptional repression of atherogenic inflammation: modulation by PPAR\u03b4. Science 302, 453\u2013457 (2003).","journal-title":"Science"},{"key":"2685_CR49","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2337\/db08-0176","volume":"57","author":"R Rodr\u00edguez-Calvo","year":"2008","unstructured":"Rodr\u00edguez-Calvo, R. et al. Activation of peroxisome proliferator-activated receptor beta\/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1\/2. Diabetes 57, 2149\u20132157 (2008).","journal-title":"Diabetes"},{"key":"2685_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.it.2004.12.003","volume":"26","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff, C. A., Khong, H. T., Antony, P. A., Palmer, D. C. & Restifo, N. P. Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol. 26, 111\u2013117 (2005).","journal-title":"Trends Immunol."},{"key":"2685_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ni.3644","volume":"18","author":"S Beyaz","year":"2017","unstructured":"Beyaz, S. et al. The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells. Nat. Immunol. 18, 184\u2013195 (2017).","journal-title":"Nat. Immunol."},{"key":"2685_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-62703-155-4_4","volume":"952","author":"T Kim","year":"2013","unstructured":"Kim, T., Zhelyabovska, O., Liu, J. & Yang, Q. Generation of an inducible, cardiomyocyte-specific transgenic mouse model with PPAR \u03b2\/\u03b4 overexpression. Methods Mol. Biol. 952, 57\u201365 (2013).","journal-title":"Methods Mol. Biol."},{"key":"2685_CR53","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.immuni.2021.08.029","volume":"54","author":"LP Andrews","year":"2021","unstructured":"Andrews, L. P. et al. A Cre-driven allele-conditioning line to interrogate CD4+ conventional T cells. Immunity 54, 2209\u20132217 (2021).","journal-title":"Immunity"},{"key":"2685_CR54","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1158\/2326-6066.CIR-22-0593","volume":"11","author":"R Yan","year":"2023","unstructured":"Yan, R., Moresco, P., Gegenhuber, B. & Fearon, D. T. T cell-mediated development of stromal fibroblasts with an immune-enhancing chemokine profile. Cancer Immunol. Res. 11, 1044\u20131054 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"2685_CR55","doi-asserted-by":"publisher","first-page":"14628","DOI":"10.1073\/pnas.95.25.14628","volume":"95","author":"RR Beerli","year":"1998","unstructured":"Beerli, R. R., Segal, D. J., Dreier, B. & Barbas, C. F. 3rd Toward controlling gene expression at will: specific regulation of the erbB-2\/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc. Natl Acad. Sci. USA 95, 14628\u201314633 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2685_CR56","doi-asserted-by":"publisher","first-page":"16788","DOI":"10.1073\/pnas.0902869106","volume":"106","author":"DJ Friedman","year":"2009","unstructured":"Friedman, D. J. et al. CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl Acad. Sci. USA 106, 16788\u201316793 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2685_CR57","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nprot.2007.41","volume":"2","author":"S Wirtz","year":"2007","unstructured":"Wirtz, S., Neufert, C., Weigmann, B. & Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541\u2013546 (2007).","journal-title":"Nat. Protoc."},{"key":"2685_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18, 529 (2017).","journal-title":"BMC Bioinformatics"},{"key":"2685_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"2685_CR60","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1158\/2767-9764.CRC-25-0193","volume":"6","author":"C Chung","year":"2026","unstructured":"Chung, C. et al. Ancestrally diverse autologous patient-derived organoid\u2013immune cell coculture platform for addressing immunotherapeutic outcome disparities in high-grade endometrial cancer. Cancer Res. Commun. 6, 657\u2013671 (2026).","journal-title":"Cancer Res. Commun."},{"key":"2685_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","volume":"169","author":"EMM Manders","year":"1993","unstructured":"Manders, E. M. M., Verbeek, F. J. & Aten, J. A. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169, 375\u2013382 (1993).","journal-title":"J. Microsc."},{"key":"2685_CR62","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41587-019-0192-1","volume":"37","author":"BD Choi","year":"2019","unstructured":"Choi, B. D. et al. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nat. Biotechnol. 37, 1049\u20131058 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2685_CR63","doi-asserted-by":"crossref","unstructured":"O\u2019Rourke, D. M. et al. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci. Transl. Med. 9, eaaa0984 (2017).","DOI":"10.1126\/scitranslmed.aaa0984"},{"key":"2685_CR64","doi-asserted-by":"crossref","unstructured":"Golubovskaya, V. et al. Novel CS1 CAR-T cells and bispecific CS1-BCMA CAR-T cells effectively target multiple myeloma. Biomedicines 9, 1422 (2021).","DOI":"10.3390\/biomedicines9101422"},{"key":"2685_CR65","doi-asserted-by":"publisher","first-page":"e8746","DOI":"10.15252\/msb.20188746","volume":"15","author":"MD Luecken","year":"2019","unstructured":"Luecken, M. D. & Theis, F. J. Current best practices in single-cell RNA-seq analysis: a tutorial. Mol. Syst. Biol. 15, e8746 (2019).","journal-title":"Mol. Syst. Biol."},{"key":"2685_CR66","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41592-019-0654-x","volume":"17","author":"RA Amezquita","year":"2020","unstructured":"Amezquita, R. A. et al. Orchestrating single-cell analysis with Bioconductor. Nat. Methods 17, 137\u2013145 (2020).","journal-title":"Nat. Methods"},{"key":"2685_CR67","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2685_CR68","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"2685_CR69","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2018.05.061","volume":"174","author":"D van Dijk","year":"2018","unstructured":"van Dijk, D. et al. Recovering gene interactions from single-cell data using data diffusion. Cell 174, 716\u2013729 (2018).","journal-title":"Cell"},{"key":"2685_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"2685_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).","journal-title":"Genome Biol."},{"key":"2685_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: An R-based toolkit for single-cell immune receptor analysis. F1000Res. 9, 47 (2020).","journal-title":"F1000Res."},{"key":"2685_CR73","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159\u2013162 (2020).","journal-title":"Nat. Methods"},{"key":"2685_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"2685_CR75","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2685_CR76","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41592-021-01282-5","volume":"18","author":"T Stuart","year":"2021","unstructured":"Stuart, T., Srivastava, A., Madad, S., Lareau, C. A. & Satija, R. Single-cell chromatin state analysis with Signac. Nat. Methods 18, 1333\u20131341 (2021).","journal-title":"Nat. Methods"},{"key":"2685_CR77","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"2685_CR78","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2021","unstructured":"Castro-Mondragon, J. A. et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 50, D165\u2013D173 (2021).","journal-title":"Nucleic Acids Res."},{"key":"2685_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2685_CR80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"2685_CR81","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295 (2015).","journal-title":"Nat. Biotechnol."},{"key":"2685_CR82","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, S. & Li, W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 28, 2184\u20132185 (2012).","journal-title":"Bioinformatics"},{"key":"2685_CR83","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & K\u00e4ller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"2685_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2685_CR85","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"2685_CR86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302785120","volume":"120","author":"M Heidarian","year":"2023","unstructured":"Heidarian, M. et al. Sublethal whole-body irradiation induces permanent loss and dysfunction in pathogen-specific circulating memory CD8 T cell populations. Proc. Natl Acad. Sci. USA 120, e2302785120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2685_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2010.10.004","volume":"267","author":"HR Park","year":"2011","unstructured":"Park, H. R. & Jo, S. K. Lasting effects of an impairment of Th1-like immune response in \u03b3-irradiated mice: a resemblance between irradiated mice and aged mice. Cell Immunol. 267, 1\u20138 (2011).","journal-title":"Cell Immunol."},{"key":"2685_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86187-1","volume":"11","author":"L Sun","year":"2021","unstructured":"Sun, L. et al. Total body irradiation causes a chronic decrease in antioxidant levels. Sci. Rep. 11, 6716 (2021).","journal-title":"Sci. Rep."},{"key":"2685_CR89","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni.3389","volume":"17","author":"BN Martin","year":"2016","unstructured":"Martin, B. N. et al. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis. Nat. Immunol. 17, 583\u2013592 (2016).","journal-title":"Nat. Immunol."},{"key":"2685_CR90","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41586-018-0846-z","volume":"565","author":"SE Weinberg","year":"2019","unstructured":"Weinberg, S. E. et al. Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature 565, 495\u2013499 (2019).","journal-title":"Nature"},{"key":"2685_CR91","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."},{"key":"2685_CR92","first-page":"3.16b.11","volume":"113","author":"GJW van der Windt","year":"2016","unstructured":"van der Windt, G. J. W., Chang, C. H. & Pearce, E. L. Measuring bioenergetics in T cells using a Seahorse Extracellular Flux Analyzer. Curr. Protoc. Immunol. 113, 3.16b.11\u201313.16b.14 (2016).","journal-title":"Curr. Protoc. Immunol."},{"key":"2685_CR93","doi-asserted-by":"publisher","first-page":"11816","DOI":"10.1096\/fj.202000678R","volume":"34","author":"M Weber","year":"2020","unstructured":"Weber, M. et al. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD. FASEB J. 34, 11816\u201311837 (2020).","journal-title":"FASEB J."},{"key":"2685_CR94","doi-asserted-by":"publisher","first-page":"e0261803","DOI":"10.1371\/journal.pone.0261803","volume":"17","author":"SA Stopka","year":"2022","unstructured":"Stopka, S. A. et al. Spatially resolved characterization of tissue metabolic compartments in fasted and high-fat diet livers. PLoS ONE 17, e0261803 (2022).","journal-title":"PLoS ONE"},{"key":"2685_CR95","doi-asserted-by":"crossref","unstructured":"Leopold, J., Popkova, Y., Engel, K. M. & Schiller, J. Recent developments of useful MALDI matrices for the mass spectrometric characterization of lipids. Biomolecules 8, 173 (2018).","DOI":"10.3390\/biom8040173"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02685-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:02:10Z","timestamp":1793055730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02685-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":95,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2685"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02685-2","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.B. received research funding from Caper Labs, Elstar Therapeutics and Revitope Oncology for research unrelated to this study. S.B. is cofounder and advisor for Caper Labs. S.B., I.E., C.C., V.S., T.M. and P.B. are listed as inventors on a patent application related to activating metabolic switches in immune cells to boost antitumor immunity (63\/460,971). N.Y.R.A. is a key opinion leader to Bruker Daltonics, has a collaboration with Thermo Finnigan, has service agreements with EMD Serono and iTeos Therapeutics and is founder of BondZ, SafeLinkZ and ChemLinkz. N.W. and S.I.G. are listed as inventors of patents related to CAR therapy. S.I.G. is a scientific cofounder and holds equity in Carisma Therapeutics and Interious Biotherapeutics. S.I.G. is a scientific advisor to Carisma, Cartography, Currus, Interius, Kite, NKILT and Mission Bio. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}